License out/inDrug Approval
3 hours ago
Cell TherapyImmunotherapyClinical Result
21 Nov 2026
Cell Therapy
21 Nov 2026
License out/inImmunotherapyCell Therapy
21 Nov 2026
AcquisitionLicense out/inADC
21 Nov 2026
Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
Clinical ResultGene TherapyAHA
21 Nov 2026
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
Clinical ResultImmunotherapyDrug ApprovalOrphan Drug
21 Nov 2026
Gastric cancer filing for AstraZeneca's Claudin 18.2-targeting ADC gets speedy FDA review
ADCClinical ResultPriority ReviewDrug Approval
21 Nov 2026
Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis
Clinical ResultFast TrackOrphan Drug
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!